顯示第 81 至 96 項結果,共 170 項
-
Anti-hapten 4-hydroxy-3-nitrophenyl acetyl (NP) [B1-8] (Ab00104-2.2)
-
Anti-hapten 4-hydroxy-3-nitrophenyl acetyl (NP) [B1-8] (Ab00104-2.3-BT)
-
Anti-hapten 4-hydroxy-3-nitrophenyl acetyl (NP) [B1-8] (Ab00104-2.3)
-
Anti-hapten 4-hydroxy-3-nitrophenyl acetyl (NP) [B1-8] (Ab00104-7.1-BT)
-
Anti-hapten 4-hydroxy-3-nitrophenyl acetyl (NP) [B1-8] (Ab00104-7.1)
-
Anti-hapten 4-hydroxy-3-nitrophenyl acetyl (NP) [B1-8] (Ab00104-7.4-BT)
-
Anti-hapten 4-hydroxy-3-nitrophenyl acetyl (NP) [B1-8] (Ab00104-7.4)
-
Anti-IL-12/23 [ABT-874 (Briakinumab)] (Ab00722-2.0-BT)
-
Anti-IL-12/23 [ABT-874 (Briakinumab)] (Ab00722-2.0)
-
Anti-IL-21R [ATR-107] (Ab01293-2.0-BT)
-
Anti-IL-21R [ATR-107] (Ab01293-2.0)
-
Anti-IL-21R [ATR-107] (Ab01293-2.3-BT)
-
Anti-IL-21R [ATR-107] (Ab01293-2.3)
-
Anti-influenza [2-8C] (Ab01103-2.0-BT)
-
Anti-influenza [2-8C] (Ab01103-2.0)
-
Anti-influenza [2-8C] (Ab01103-2.3-BT)
